The abstract is read at the publisher; the summary is JClub's.
PReP-Bicyc enables phage-displayed peptide bicyclization using 4,6-DCCPm, yielding PD-1 ligands with best Kd ≈ 400 nM that selectively label PD-1–expressing cells.
- Why it matters: Bicyclic peptides are promising for stability and binding, but phage display has lacked phage-compatible chemistries to generate them site-selectively.
- What they did: The additive-free method uses 4,6-DCCPm to form a nitrile-mediated thiazoline with an N-terminal cysteine, then proximity-driven intramolecular thiol arylation of two internal cysteines, preserving phage viability.
- The result: Screening a PReP-Bicyc-modified CX4CX4C library against PD-1 identifies sub-micromolar bicyclic ligands that inhibit the PD-1/PD-L1 interaction and selectively label PD-1–expressing cells.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.